According to World Health Organisation (WHO) an estimated 36.9 [34.3–41.4] million people were living with HIV (PLWH) at the end of 2014, of whom 25.8 [24.0–28.7] million were in sub-Saharan Africa .
In the third decade of the pandemic, despite numerous interventions in the fight against HIV/AIDS by global health initiatives such as (the Global Fund to Combat AIDS, Tuberculosis and Malaria (Global Fund)), the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), Joint United Nation Programme On HIV/AIDS (UNAIDS)) the gap between low-income and high-income countries with reference to universal access to prevention, care and treatment is still huge.
The CASA – project aims to provide a contribution to improvement of HIV/AIDS patient care through a holistic approach including training, operational research methods along with the active participation of patients’ Associations.
In Italian, “CASA” means “HOME” a world that fully represents the inner of the project: a home for all of you who wish to share CASA objectives and contribute to improve the quality of care of people. The CASA- project approach could in the next future be extended not only to patients with HIV-infection but also to them with other diseases such as the not communicable diseases (NCDs).
Many sub-Saharan countries are experiencing the epidemiological transition in which CDs co-exist with the new NCDs. Although the CDs are still the prevalent health problem in these countries, the chronic NCDs are becoming one the principal challenges to be faced. This matter calls for an urgent intervention for policies for control of the new double burden of disease. HIV infection is characterized by being a chronic infection which impact throughout lifecycle, with periods of illness and periods of wellness, with multiple clinical and psychosocial needs, needing life-long care and treatment and secure supply of medicines and laboratory tests. The same picture is applicable to other chronic conditions, which requires demand and access to services, health personnel training, support for adherence, infrastructure and equipment, drug and laboratory supplies, great attention to linkage to care and, finally, the need for an important community involvement and educational campaigns for people.